4-MMPB
Based on 1 Customer Validation
4-MMPB is a selective inhibitor of 15-lipoxygenase, with an IC50 of 18 μM. 4-MMPB has IC50s of 19.5 μM and 19.1 μM for soybean 15-lipoxygenase (SLO) and human 15-lipoxygenase-1 (15-LOX-1), respectively. 4-MMPB has potential for the research of prostate cancer.
Para uso exclusivo en investigación. No vendemos a pacientes.
- Pureza : 98.54%
- No. CAS: 928853-86-5
- Fòrmula: C16H19N5S
- Peso molecular:313.42
-
Almacenamiento:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Actividad biológica
-
Chemical Information
-
Solvente y solubilidad
- Pureza y Documentación
- Referencias
-
Help & FAQs
-
HY-14164
Zileuton5-Lipoxygenase Inhibitor -
HY-103157
PD14617615-LO Inhibitor -
HY-12341
Onvoloxastat12-LOX Inhibitor -
HY-N1942
5-O-Demethylnobiletin5-LOX Inhibitor -
HY-119671
BW 755C5-LO/COX Inhibitor -
HY-N0284
EsculetinPI3K Inhibitor -
HY-A0060
Malotilate5-LOX Inhibitor -
HY-14164A
Zileuton sodium5-lipoxygenase Inhibitor -
HY-N0892
AKBANrf2 Activator -
HY-N0248
Saikosaponin B2Solute Carrier Modulator, ATP-Binding Cassette Transporter Modulator -
HY-13219
TepoxalinCyclooxygenase/Lipoxygenase Inhibitor -
HY-111310
ML35115-LOX-1 Inhibitor
Actividad biológica
Descripciòn
IC50 & Target
IC50: 18 μM (15-lipoxygenase)[1]
In Vitro
4-MMPB has an IC50 of 69.6 μM for DPPH bleaching[2].
4-MMPB exhibits cytotoxic activity on human PC-3 and HFF3 cell lines[4].
4-MMPB (41.48 μM; 72 hours) induces apoptosis and DNA damage in PC-3 Cells[4].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:DU145 cells, PC-3 cells, HFF3 cells
-
Concentration:9.57 µM, 19.94 µM, 39.88 µM, 79.77 µM,159.53 µM
-
Incubation Time:24 hours, 48 hours, 72 hours
-
Result:Inhibited cells viability (IC50=79.76 µM; 24 h, 51.05 µM; 48 h, 41.48 µM; 72 h for PC-3 cells, IC50=255.25 µM; 24 h, 130.81 µM; 48 h, 98.91 µM; 72 h for HFF3 cells).
Chemical Information
-
No. CAS 928853-86-5
-
Appearance Solid
-
Peso molecular 313.42
-
Fòrmula C16H19N5S
-
Color Light yellow to orange
-
SMILES
CC1=C2NC3=C(SC2=NC(N4CCN(CC4)C)=N1)C=CC=C3
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Solvente y solubilidad
In Vitro:
DMSO : 7.69 mg/mL (24.54 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
In Vivo:
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 0.77 mg/mL (2.46 mM); Clear solution
This protocol yields a clear solution of ≥ 0.77 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (7.7 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 0.77 mg/mL (2.46 mM); Clear solution
This protocol yields a clear solution of ≥ 0.77 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (7.7 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL.
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Pureza y Documentación
-
Ficha de datos (274 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Instrucciones de manejo (2659 KB)
Referencias
[1]. M Bakavoli, et al. Design and synthesis of pyrimido[4,5-b][1,4]benzothiazine derivatives, as potent 15-lipoxygenase inhibitors. Bioorg Med Chem. 2007 Mar 1;15(5):2120-6. [Content Brief]
[3]. Seyed Jamal Alavi, et al. A novel class of human 15-LOX-1 inhibitors based on 3-hydroxycoumarin. Chem Biol Drug Des. 2018 Jun;91(6):1125-1132. [Content Brief]
[4]. Saffiyeh Saboormaleki, et al. 7-Farnesyloxycoumarin Exerts Anti-cancer Effects on a Prostate Cancer Cell Line by 15-LOX-1 Inhibition. Arch Iran Med. 2018 Jun 1;21(6):251-259. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 3.1906 mL | 15.9530 mL | 31.9061 mL | 79.7652 mL |
| 5 mM | 0.6381 mL | 3.1906 mL | 6.3812 mL | 15.9530 mL | |
| 10 mM | 0.3191 mL | 1.5953 mL | 3.1906 mL | 7.9765 mL | |
| 15 mM | 0.2127 mL | 1.0635 mL | 2.1271 mL | 5.3177 mL | |
| 20 mM | 0.1595 mL | 0.7977 mL | 1.5953 mL | 3.9883 mL |
4-MMPB Related Classifications
HY-118480 Related Classifications
Powered by Bioz